Singapore markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1200+0.0360 (+3.32%)
At close: 01:57PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
119,245
108,096
76,701
79,660
52,432
Cost of revenue
54,779
48,058
38,774
37,655
22,990
Gross profit
64,466
60,038
37,927
42,005
29,442
Operating expenses
Research development
8,802
2,943
5,873
4,596
1,098
Selling general and administrative
40,883
48,253
44,032
36,172
28,934
Total operating expenses
49,973
51,549
50,303
41,274
30,482
Operating income or loss
14,493
8,489
-12,376
731
-1,041
Interest expense
15,648
13,606
12,223
9,819
6,442
Total other income/expenses net
118
76
20,779
-22,416
3,254
Income before tax
-1,037
-5,041
-3,820
-31,501
-5,188
Income tax expense
-5,944
-6,262
-941
-3,237
-790.4386
Income from continuing operations
4,907
1,221
-2,879
-28,264
-4,397
Net income
4,907
1,221
-2,879
-28,264
-4,397
Net income available to common shareholders
4,907
1,221
-2,879
-28,264
-4,397
Basic EPS
-0.51
0.06
-0.15
-1.86
-0.33
Diluted EPS
-0.52
0.06
-0.15
-1.86
-0.33
Basic average shares
18,877
19,976
19,454
15,197
14,360
Diluted average shares
20,774
20,524
19,856
15,197
14,360